Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

76 results about "Aminopenicillanic acid" patented technology

6-APA is the chemical compound (+)-6-aminopenicillanic acid. Use. 6-APA is the core of penicillins. It is obtained from the fermentation brew of the Penicillium mold and used as the main starting block for the preparation of numerous semisynthetic penicillins. History. In 1958, Beecham scientists in the UK discovered the ...

Preparation method of benzhydryl s-oxopenicillanate

The invention provides a preparation method of benzhydryl s-oxopenicillanate, which comprises the following steps: reacting 6-aminopenicillanic acid to obtain a penicillanic acid (iii) solution; adding catalyst molybdenum acetopyruvate, and dropwisely adding oxydol while controlling the temperature; after the reaction finishes, centrifuging to obtain oxopenicillanic acid; and reacting to obtain the benzhydryl s-oxopenicillanate. The method provided by the invention has the following advantages: 1. simplified synthesis steps: the processes of bromination and reduction debromination are not adopted; 2. short reaction period: only three reaction steps are adopted, thereby greatly shortening the production period; 3. favorable reaction selectivity and high yield: the total yield of the three steps for preparing the benzhydryl s-oxopenicillanate is higher than 72%; 4. mild reaction conditions: the high-risk hydrogenation reaction is not needed; and 5. the separation of the product and the intermediates is simple to operate, the two intermediates in the benzhydryl s-oxopenicillanate synthesis route can be directly used for synthesizing the required compound without refinement, and the end product can be directly filtered and separated.
Owner:JIANGXI FUSHINE PHARMA CO LTD

Tazobactam synthesis method

ActiveCN102643292ASteps to increase monoxidationBlocking affinityOrganic chemistryMetacresolSynthesis methods
The invention discloses a tazobactam synthesis method, which belongs to the technical field of medicines, and includes the steps: firstly, enabling 6,6-dihydropenam sulfoxide acid diphenylmethyl ester serving as raw materials to undergo thermal cracking and chloromethylation reaction to obtain 2beta-chloromethyl penicillanic acid diphenylmethyl ester; secondly, adding oxidizing agent to oxidize the 2beta-chloromethyl penicillanic acid diphenylmethyl ester-1beta-oxide, enabling the oxidized 2beta-chloromethyl penicillanic acid diphenylmethyl ester-1beta-oxide to react with sodium azide to generate 2beta-hydrazoic methyl penicillanic acid diphenylmethyl ester-1beta- oxide, and then generating 2beta-hydrazoic methyl penicillanic acid diphenylmethyl ester-1,1- dioxide by means of oxidization under the action of potassium permanganate and acetic acid; and finally, preparing the tazobactam by means of deprotection under the action of acetylene cyclization and metacresol. Compared with a past 6-APA (aminopenicillanic acid) route, the tazobactam synthesis method has the advantages that the step of sulfur atom single oxidization is added, so that possibility of ring expansion due to affinity of lone pair electrons on a sulfur atom is blocked, and transformation of five-membered ring products to six-membered ring by-products during hydrazoic reaction can be effectively controlled.
Owner:山东安信制药有限公司 +1

Improved method for preparing amoxicillin by enzymic method

The invention relates to the field of pharmacy, and provides an improved method for preparing amoxicillin by an enzymic method, and a product obtained by the improved method for preparing amoxicillin by the enzymic method. The method comprises the following steps of: 1) dissolving 6-aminopenicillanic acid (6-APA) at the temperature of between 10 and 20 DEG C by using water or/and aqueous solution of ammonia which has the pH value of 7.0 to 8.0, and adding D-p-Hydroxyphenylglycine methyl ester hydrochlorid and penicillin G acyltransferase; 2) adjusting the pH value of a solution obtained in the step 1) to be 6.0 to 6.5, and reacting at the temperature of between 21 and 30 DEG C until the content of 6-APA is less than 5mg/ml to obtain a solution of an amoxicillin product; and 3) separating the penicillin G acyltransferase from the solution of the amoxicillin product, adjusting by using hydrochloric acid until the solution of the amoxicillin product is clarified, adding the aqueous solution of ammonia, adjusting the pH value to be 5.5 to 6.5, and crystallizing at the temperature of between 0 and 5 DEG C to obtain amoxicillin. By the improved method for preparing amoxicillin by the enzymic method, the quality of the amoxicillin product is greatly improved, and the medication safety of the amoxicillin product is further improved.
Owner:UNITED LAB INNER MONGOLIA CO LTD

Synthesizing method of sulbactam acid

The invention discloses a synthesizing method of sulbactam acid. The method comprises the steps that: (1) under the existence of a strong acid, 6-aminopenicillanic acid, a diazotization reagent, and bromine or bromide are subjected to an insulation reaction in an organic solvent; excessive bromine is reduced; and a reaction product is extracted to a water layer; (2) an oxidant is dropped into the water-layer reaction product, and an insulation reaction is carried out; when the reaction is finished, a pH value is regulated; excessive potassium permanganate is reduced; an organic solvent is added, such that a reaction product is extracted to an organic solvent layer; (3) a catalyst is added into the organic-solvent layer product, such that hydrogenation bromine-removing is carried out; a reaction product is extracted to an organic-solvent layer; and distillation and crystallization are carried out. The organic solvent is ethyl acetate. According to the invention, ethyl acetate is adopted as the organic solvent in a four-step reaction, such that solvent consumption of the whole reaction is greatly reduced, and product total yield is effectively improved. With the method provided by the invention, by-product in the reaction can be comprehensively utilized, and advantages such as high yield, low cost, clean production, and the like are provided.
Owner:LIANYUNGANG HENGFEI PHARMA

Method for recovering phenylacetic acid from waste liquid in preparation of 6-aminopenicillanic acid by enzymic method

The invention relates to a method for recovering phenylacetic acid from waste liquid in preparation of 6-aminopenicillanic acid by an enzymic method. The method comprises the following steps: 1) using toluene to extract phenylacetic acid; 2) preparing a sodium phenylacetate aqueous solution with little impurity; and 3) using macroreticular resin for recovering phenylacetic acid from a water phase containing low-concentration phenylacetic acid. According to the invention, toluene is extracted from waste liquid in preparation of 6-aminopenicillanic acid by the enzymic method, a toluene phase containing phenylacetic acid and a water phase containing low-concentration phenylacetic acid are obtained; the toluene phase containing phenylacetic acid is extracted through alkali lye to obtain the sodium phenylacetate aqueous solution with high quality, the sodium phenylacetate aqueous solution can be directly used for producing penicillin through fermentation; the water phase containing low-concentration phenylacetic acid is pretreated for recovering sodium sulfate, macroreticular resin is used for absorbing phenylacetic acid for recovery, the low concentration water after adsorption can be directly discharged, zero discharge of phenylacetic acid can be almost realized, win-win of economy and environmental protection can be achieved, the by-product sodium sulfate can be used for fermentation, and also has economic benefit.
Owner:SHANXI WEIQIDA PHARMA IND

Technology for preparing ampicillin by adopting enzymic method

ActiveCN103805672AOvercoming conversion rateOvercome purityFermentationAmpicillinSolvent
The invention discloses a technology for preparing ampicillin by adopting an enzymic method. The technology comprises the following steps of (a) mixing 6-aminopenicillanic acid, a phenylglycine derivative and penicillin G acylase into water to obtain mixed liquid; (b) adjusting and controlling the pH value of the mixed liquid to be 5.5-6.1 through acid or alkaline, and reacting under the temperature of 0-40 DEG C; (c) after the reaction is finished, performing separation, cleaning reaction liquid containing a coarse ampicillin product through the acid, crystallizing the reaction liquid through the alkaline, and performing grain cultivation, washing and drying to obtain an ampicillin product. The preparation technology provided by the invention is simple, convenient to operate, low in energy consumption, high in safety and high in stability; furthermore, the pH value required by a reaction system is easy to control, the reaction time is short, the conversion rate is up to over 99 percent, the product purity is high, and a solvent does not need to be recycled; and therefore, the low-cost and high-efficiency production technology can be popularized and applied in the industrial production.
Owner:NORTH CHINA PHARM GRP SEMISYNTECH CO LTD

6-aminopenicillanic acid degrading bacterium and screening method thereof

ActiveCN103184177AImprove the ability to hydrolyze 6-aminopenicillanic acidBacteriaWater contaminantsMicroorganismScreening method
The invention relates to a 6-aminopenicillanic acid (6-APA) degrading bacterium and a screening method thereof. Particularly, the invention relates to a strain of 6-APA degrading bacterium Bordetella sp.L2, which is preserved in China General Microbiological Culture Collection Center (CGMCC) on October 18, 2012, with the preservation number of CGMCC No. 6691; and the GenBank registration number of the 16S rRNA gene sequence of the 6-APA degrading bacterium Bordetella sp.L2 is HQ840720. The 6-APA degrading bacterium Bordetella sp.L2 is an aerobic bacillus brevis; and when the pH value is 8.0, the 6-APA degradation rate of the 6-APA degrading bacterium Bordetella sp.L2 is 28%. The strain achieves higher 6-APA degradation capability and has a practical significance and an important engineering application value for treatment of waste water containing 6-APA cephalosporin.
Owner:CHINA THREE GORGES CORPORATION

Method for crystallizing cloxacillin sodium

InactiveCN102070653AOvercome the defects of fine and difficult to filterSolve problems such as non-conformityOrganic chemistryFiltrationDistillation
The invention provides a method for crystallizing cloxacillin sodium, which comprises the following steps: weighing 6-aminopenicillanic acid and 3-chloro-O-phenyl-5-methyl-4-isoxazole acyl chloride according to a mass ratio of 1.0 / 0.5 to 2.5; adding water and acetone into the 6-aminopenicillanic acid to prepare a solution A; adding the 3-chloro-O-phenyl-5-methyl-4-isoxazole acyl chloride into the acetone to prepare a solution B; adding the solution B into the solution A to be uniformly stirred for carrying out acidylation reaction for 0.5 to 4h; adding acid for acidification after the reaction is completed, and adding mixed liquid of lower alcohol and butyl acetate for extraction; adding sodium iso-octoate organic solution for carrying out salt forming reaction, and carrying out reduced pressure distillation and crystal growing; and carrying out suction filtration, washing and drying. In the method provided by the invention, the product quality and the yield of the cloxacillin sodium can be effectively improved, the production period is shortened, and the production cost is reduced.
Owner:河北华日药业有限公司

Penicillin fermentation broth treating technology

ActiveCN103214498ADetermining the concentrationDetermine the quantitySemi-permeable membranesOrganic chemistryCross-flow filtrationCephalosporanic Acids
The invention discloses a penicillin fermentation broth treating technology, which comprises the following steps of: cooling an original penicillin fermentation broth, filtering the cooled penicillin fermentation broth by a closed ceramic-membrane cross-flow filtration system, and collecting high-titer ceramic-membrane filtrate; during filtration, when the wet solid content in the penicillin fermentation broth is enhanced to 1.8-2 times that of the original fermentation broth, adding water with weight accounting for 2 times that of the original fermentation broth for dialyzing to obtain and collect low-titer ceramic-membrane filtrate, and then nano-filtering, concentrating and dewatering the low-titer ceramic-membrane filtrate for later use; continuing to add water with weight accounting for 2 times that of the original fermentation broth for dialyzing to obtain and collect ultra-low-titer ceramic-membrane filtrate; stopping filtration until the titer of penicillin in the penicillin fermentation broth is low to 500-800U; collecting bacterium dregs intercepted by the ceramic-membrane filtration system; putting the high-titer ceramic-membrane filtrate in 6APA (6-aminopenicillanic acid) for conversion or oxidization, ring enlargement and cracking, thus preparing 7-ADCA (7-aminodeacetoxy cephalosporanic acid); and collecting the obtained bacterium dregs and adding engineering bacteria for decomposing the bacterium dregs.
Owner:河北美邦工程科技股份有限公司 +1

Tazobactam synthesis method

ActiveCN102643292BSteps to increase monoxidationBlocking affinityOrganic chemistryMetacresolSynthesis methods
The invention discloses a tazobactam synthesis method, which belongs to the technical field of medicines, and includes the steps: firstly, enabling 6,6-dihydropenam sulfoxide acid diphenylmethyl ester serving as raw materials to undergo thermal cracking and chloromethylation reaction to obtain 2beta-chloromethyl penicillanic acid diphenylmethyl ester; secondly, adding oxidizing agent to oxidize the 2beta-chloromethyl penicillanic acid diphenylmethyl ester-1beta-oxide, enabling the oxidized 2beta-chloromethyl penicillanic acid diphenylmethyl ester-1beta-oxide to react with sodium azide to generate 2beta-hydrazoic methyl penicillanic acid diphenylmethyl ester-1beta- oxide, and then generating 2beta-hydrazoic methyl penicillanic acid diphenylmethyl ester-1,1- dioxide by means of oxidization under the action of potassium permanganate and acetic acid; and finally, preparing the tazobactam by means of deprotection under the action of acetylene cyclization and metacresol. Compared with a past 6-APA (aminopenicillanic acid) route, the tazobactam synthesis method has the advantages that the step of sulfur atom single oxidization is added, so that possibility of ring expansion due to affinity of lone pair electrons on a sulfur atom is blocked, and transformation of five-membered ring products to six-membered ring by-products during hydrazoic reaction can be effectively controlled.
Owner:山东安信制药有限公司 +1

Synthesis method of sulbactam acid

The invention relates to the field of medicine synthesis and provides a synthesis method of sulbactam acid, aiming at the problem of low yield of a traditional synthesis manner. The synthesis method comprises the following steps: S1, carrying out diazotization and bromination reaction: adding bromine, a dilute sulfuric acid solution and a sodium nitrite solid into 6-aminopenicillanic acid, whereinthe concentration of the dilute sulfuric acid solution is 20 to 25 percent; reacting to obtain a first intermediate; S2, carrying out oxidization reaction: dropwise adding potassium permanganate andthe dilute sulfuric acid solution into the first intermediate, wherein the concentration of the dilute sulfuric acid solution is 20 to 25 percent; S3, carrying out hydrogenation reaction: dropwise adding zinc powder and the dilute sulfuric acid solution into a second intermediate and reacting to obtain the sulbactam acid. The dilute sulfuric acid solution with the concentration of 20 to 25 percentis used for reacting, which facilitates the improvement of the activity of the diazotization and bromination reaction and the oxidization reaction, and reactants are enabled to react more completely,so that the improvement of the yield of the diazotization and bromination reaction and the oxidization reaction is facilitated, and the total yield of the reaction is further improved.
Owner:常州红太阳药业有限公司

Method for compounding flucloxacillin sodium-hydrate

The invention discloses a method for compounding flucloxacillin sodium-hydrate, which belongs to the technical field of drug synthesis, and comprises the steps: 6-aminopenicillanic acid (6-APA) is salified, then 3-(2-chloro-6-fluorophenyl)-5- methyl isoxazole-4-formyl chloride or equivalents thereof are added to do an acylation reaction, and then acids are added drop by drop to adjust a potential of hydrogen (pH) value to obtain flucloxacillin acid aqueous solutions. Organic solution is used to extract, and organic phases are washed, dried and filtered to obtain flucloxacillin acid solutions through saturated salt water, then white solids are dissolved out in the flucloxacillin acid solutions which are added with sodium iso-octoate solutions, and products are obtained by controlling temperature and crystallizing. The method for compounding the flucloxacillin sodium-hydrate does not separate intermediate flucloxacillin acids, obtained flucloxacillin acids are directly salified with sodium iso-octoate after being extracted trough the organic solution, reduces separation steps and operation process, also reduces usage amount and times of organic solution simultaneously, greatly reduces discharge amount of organic solution relative to patent documentation CN 102964356A, reduces production cost above 20%, and obviously improves economic and environmental values.
Owner:CHENGDU LIKAI CHIRAL TECH

Penicillin V acylase mutant, encoding array, recombinant expression vector, genetically engineered bacterium and application

The invention provides a penicillin V acylase mutant, an encoding array, a recombinant expression vector, a genetically engineered bacterium and application. Penicillin V acylase derived from Bacillussphaericus is mutated, the specific activity of the obtained mutant PVA-3 is improved by nine times, the immobilization activity is improved to 820U / g from 92U / g, and after being incubated for one hour under a condition of 30% penicillin V sylvite, the mutant has activity residue of 89.1%; the reaction time that the immobilized mutant PVA-3 is adopted to prepare 6-APA (6-Aminopenicillanic Acid) by splitting 25% penicillin V under a condition that the pH value is 6.0 at 25 DEG C is shortened to 60 minutes from 180 minutes, a substrate conversion rate is increased to 99.5% or greater, the activity is not greatly lost after continuous use for 600 times or greater, and good operation stability can be achieved. By adopting the mutated PVA-3, the production cost can be greatly reduced, the production efficiency can be improved, and the mutant is applicable to industrial application.
Owner:HUNAN FLAG BIOTECHNOLOGY CO LTD

Synthesizing method of sulbactam acid

The invention discloses a synthesizing method of sulbactam acid. The method comprises the steps that: (1) under the existence of a strong acid, 6-aminopenicillanic acid, a diazotization reagent, and bromine or bromide are subjected to an insulation reaction in an organic solvent; excessive bromine is reduced; and a reaction product is extracted to a water layer; (2) an oxidant is dropped into the water-layer reaction product, and an insulation reaction is carried out; when the reaction is finished, a pH value is regulated; excessive potassium permanganate is reduced; an organic solvent is added, such that a reaction product is extracted to an organic solvent layer; (3) a catalyst is added into the organic-solvent layer product, such that hydrogenation bromine-removing is carried out; a reaction product is extracted to an organic-solvent layer; and distillation and crystallization are carried out. The organic solvent is ethyl acetate. According to the invention, ethyl acetate is adopted as the organic solvent in a four-step reaction, such that solvent consumption of the whole reaction is greatly reduced, and product total yield is effectively improved. With the method provided by the invention, by-product in the reaction can be comprehensively utilized, and advantages such as high yield, low cost, clean production, and the like are provided.
Owner:LIANYUNGANG HENGFEI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products